OncologyTube Professional - Patients Click Here
thoraciconcology
29,416 video views
Loading........
Description: Roy S. Herbst, MD, PhD of Yale Cancer Center talks about EGFR inhibitor resistant patients and how EGFR antibodies may play a role. With over 20 years of experience in treating patients, Roy has seen ...
00:54
Roy S. Herbst, MD, PhD of Yale Cancer Center talks about EGFR inhibitor resistant patients and how EGFR antibodies may play a role. With over 20 years of experience in treating patients, Roy has seen that patients progressed in some way on these drugs. The data they have for the EGFR antibodies with...
by:thoraciconcology | 475 views
01:04
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses EGFR small molecules versus antibodies in combination antibodies better than small molecules. He explains that small molecules against EGFR versus antibodies work by different mechanisms and might have different activities. The antibodies agains...
by:thoraciconcology | 210 views
01:23
Jun J. Mao, MD of Memorial Sloan Kettering Cancer Center explains why oncologic supplements and diet correlative evidence is incomplete and how physicians should emphasize safety first. As an integrative oncology specialist, a lot of patients came to him and asked what kind of supplements to eat or ...
by:thoraciconcology | 203 views
01:20
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses how the FLAURA data & Osimertinib result in high PFS as front-line agent compared to the standard erlotinib and gefitinib. Although the survival data are not yet mature, the result is quite compelling with a strong trend for overall survival...
by:thoraciconcology | 264 views
01:25
Jun J. Mao, MD of Memorial Sloan Kettering Cancer Center discusses how physical activity and fitness help lung cancer patients get better prognosis and better outcomes. Many patients, when diagnosed with cancer or beginning to start getting chemo, started to feel exhausted that it can get worse. The...
by:thoraciconcology | 251 views
03:05
Jim L. Mulshine, MD of Rush University talks about the 2015 lung cancer screening data from the American Cancer Society, why it’s low and what has been done to increase the number. In 2015, the total number of patients screened was only 300,000 for the whole year. This is not surprising as the proce...
by:thoraciconcology | 226 views
00:39
Jennifer S. Temel, MD of Mass General Hospital - Harvard Medical School explains how engaging patients talk about end of life care could actually cut costs. Dr. Temel says that the discussion of cost don’t come in patient-clinici​an communication about the end of life care. However, data suggests tha...
by:thoraciconcology | 179 views
01:06
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses lung cancer EGFR antibodies and where the research is going. His says that immunotherapy is all the rage these days, which is only working on about 20% of the patients. And, as a single-angle frontline, it is only using 50% or more PD-L1 positiv...
by:thoraciconcology | 228 views
01:03
Jun J. Mao, MD of Memorial Sloan Kettering Cancer Center discusses the definition of integrative oncology which they published a special issue at the Journal of the National Cancer Institute Monographs. They defined integrative oncology as to bring natural products, mind, body therapies and lifestyl...
by:thoraciconcology | 146 views
02:12
Jim L. Mulshine, MD of Rush University talks about computed tomography which can be used not just for lung cancer screening but for tobacco-related diseases as well. CT looks at the anatomical features of the lung where the collision of tobacco smoke going on, resulting to destruction of lung parenchyma, coronary artery occlusion and related cancer...
by:thoraciconcology | 141 views

About thoraciconcology


Links
Channel Url:

Website: